The Canadian experience with long term deflazacort treatment in Duchenne muscular dystrophy

Deflazacort is the most commonly prescribed corticosteroid for the treatment of Duchenne muscular dystrophy in Canada. We review the long term experience with deflazacort treatment at two centers in Canada; Montreal and Toronto. Deflazacort has benefitted both cohorts by prolonged ambulation, preser...

Descripción completa

Detalles Bibliográficos
Autores principales: McADAM, LAURA C., MAYO, AMANDA L., ALMAN, BENJAMIN A., BIGGAR, W. DOUGLAS
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pacini Editore SpA 2012
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3440807/
https://www.ncbi.nlm.nih.gov/pubmed/22655512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3440807/
https://www.ncbi.nlm.nih.gov/pubmed/22655512

Ejemplares similares